Sitero Announces Explosive Growth, Surpassing 100 Customers on its Mentor eCompliance Platform
MIAMI, Feb. 20, 2025 /PRNewswire/ -- Sitero, a leading provider of Clinical Trial and Research Compliance Technology, today announced it...
Day: February 20, 2025
IntellaTriage Achieves HITRUST Certification, Setting the Standard for Cybersecurity in Nurse Triage
IntellaTriage, the nation's leading provider of nurse-first triage solutions, recently earned HITRUST i1 certification for its proprietary triage platform, IntellaHub....
Evogene Schedules Fourth Quarter 2024 Financial Results Release
Zoom conference call scheduled for March 6, 2025, 9:00 AM ET REHOVOT, Israel, Feb. 20, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq:...
Valencia Technologies Announces Strategic Investment of up to $35 Million and Appointment of James D. Surek as Chief Executive Officer
Company Positioned for Accelerated Growth with Infusion of Capital and Proven Commercial Leadership VALENCIA, Calif., Feb. 20, 2025 /PRNewswire/ --...
Eyesafe Reinvents Blue Light Glasses: 2X Protection for Eyes and Sleep & New Requirements for Blue Light Eyewear
Developed in collaboration with top ophthalmologists and optometrists, Eyesafe® Eyewear features advanced lens technology by BluTech, designed to reduce eye...
ADIA Nutrition Proudly Launches Adia Labs LLC and Begins Sales of Branded Stem Cell Products
Winter Park, Florida--(Newsfile Corp. - February 20, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a trailblazer in healthcare and...
Ezra Announces New FDA Clearance, Enhancing the Capabilities of Its Full-Body Scan Technology
The latest clearance enables new, faster scan options for more patientsNEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Ezra, the...
COEPTIS’ NexGenAI Partners with Arketyp Valu to Revolutionize Digital Engagement on the Verus Network
The Strategic Collaboration Integrates Cutting-Edge Marketing Tools into the ValuSocial Platform, Leveraging the Robust Capabilities of Verus Coin and Blockchain...
Precision Optics Announces Pricing of $5.1 Million Offering of Common Stock to Fund Business Expansion
GARDNER, Mass., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of...
Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn’s and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025
– SL-325 is a high-affinity DR3 blocking antibody being developed for the treatment of inflammatory bowel disease (IBD); No evidence of toxicity...
HWH International Inc. Announces Reverse Stock Split
BETHESDA, MD, Feb. 20, 2025 (GLOBE NEWSWIRE) -- HWH International Inc. (the “Company”) (NASDAQ: HWH), a purpose-driven lifestyle company, today...
Palisade Bio, Inc. Announces Receipt of Cash Proceeds from Canada’s SR&ED Tax Incentive Program for Reimbursement of Development Costs of PALI-2108 for Treatment of Ulcerative Colitis (UC)
Company through its co-development partner, Giiant Pharma, Inc. (“Giiant”), receives funding from Canadian Scientific Research and Experimental Development (SR&ED) Tax...
SELLAS Announces Positive Data from Phase 2a Trial of SLS009 in Combination with Zanubrutinib in DLBCL
- Combination Achieved a 67% of Overall Response Rate, More than Double that of Zanubrutinib Alone; 83% Disease Control Rate...
OXB’s lentiviral vector manufacturing technology to support Boehringer Ingelheim’s newly initiated Phase I/II trial of first-in-class gene therapy for cystic fibrosis
OXB’s lentiviral vector manufacturing technology to support Boehringer Ingelheim’s newly initiated Phase I/II trial of first-in-class gene therapy for cystic...
Intelligent Bio Solutions Inc. Announces Pricing of $2.6 Million Public Offering of Common Stock
NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a medical technology company...
Aphaia Pharma to Participate in Panel Discussion at SXSW 2025
ZUG, Switzerland and SAN JUAN, Puerto Rico and TORONTO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Aphaia Pharma, a clinical-stage company...
BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program
– Underscores high unmet need for a therapeutic alternative to opioids and surgical interventions – – Reflects positive preliminary Phase...
PolarityBio Receives U.S. FDA Breakthrough Therapy Designation for Treatment of Wagner Grade I Diabetic Foot Ulcers (DFU)
The FDA has granted Breakthrough Therapy Designation for SkinTE based on key positive data from the Phase II study in...
IMUNON to Hold 2024 Financial Results and Business Update Conference Call on Thursday, February 27, 2025
LAWRENCEVILLE, N.J., Feb. 20, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its...
Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting
Presentation to highlight Autonomix’s catheter-based technology and key findings from lead-in patients in ongoing human clinical trial in pancreatic cancer...